CareMax Inc is a healthcare services company that focuses on delivering high-quality, coordinated care for senior patients, particularly those on Medicare. Through its network of primary care clinics, CareMax provides a range of services including preventive care, chronic disease management, and wellness programs. The company leverages technology and data analytics to enhance patient engagement and improve health outcomes, ensuring that seniors receive personalized care tailored to their individual needs. By integrating clinical services with community resources, CareMax aims to promote healthier lifestyles and mitigate the challenges faced by elderly patients in navigating the healthcare system. Read More
CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced that it has entered into a “stalking horse” purchase agreement with ClareMedica Health Partners (“ClareMedica”), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax’s core centers’ assets including a vast majority of CareMax’s operating clinics (the “Core Centers’ Assets”).
CareMax Inc. announces asset sales under a Chapter 11 plan, backed by lenders, and secures $30.5 million in financing. Key details on management services divestment.
CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization and also announced a sale process for the Company’s core centers’ assets (collectively, the “Sale Transactions”). The Sale Transactions will be implemented pursuant to a prearranged chapter 11 plan supported and funded by 100 percent of CareMax’s current secured lenders (the “Prearranged Plan”).
CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024.
